WORLD CONFERENCE ON REGENERATIVE MEDICINE IN LEIPZIG IS ATTENDED BY HUNDREDS OF SCIENTIST AND PHYSICIANS FROM ALL OVER THE WORLD
On November 2–4, 2011, Leipzig will once again host numerous international experts, including the next generation of scientists who are conducting research within the complex field of Regenerative Medicine. During World Conference on Regenerative Medicine, they will discuss their latest findings and results. The main topics of the conference are new stem-cell technologies as well as therapies, tissue engineer ing, and biomaterials.
Conference President Prof. Dr. Frank Emmrich is enthusiastic about the event. “I am very happy that this conference is bringing together so many inter-nationally esteemed scientists and exhibitory companies, as well,” he says. “The conference offers the unique possibility to intensify the interdisciplinary exchange among the experts. It also clearly shows that the location of Leipzig is a sufficient and attractive one when it comes to Regenerative Medicine.” Emmrich is the head of the Fraunhofer Institute for Cell Therapy and Immuno-logy, as well as director of the Translational Centre for Regenerative Medicine at the University of Leipzig. The Conference is organized in cooperation by both of them. It is the 5th of its kind, and it is already one of the biggest in Europe.
Notable keynote speakers include Dr. Andras Nagy, from the Samuel Lunenfeld Research Institute of the Mount Sinai Hospital in Toronto, and Dr. Kun Zhang, from the Dpt. of Bioengineering at the University of California in San Diego. Both are dealing with the methods of reprogramming somatic cells back into pluripotent stem cells (iPS cells) and their potential for therapeutic applications. Additionally, the German stem cell expert Prof. Dr. Jürgen Hescheler, from the University of Colone, will speak about the obstacles and perspectives of the therapeutic application of stem cells.
Biological Engineer Prof. Dr. Laura Niklason, from the Yale School of Engineering and Applied Science in New Haven, discusses the progress and challenges of lung regeneration. Apart from human applications, veterinarian research will also be presented. In contrast to human medicine, many of the regenerative medical treatments have already successfully entered the clinical setting. Results gained from veterinary patients offer valuable preclinical information for future clinical applications in humans. Among the notable scientists, Professor Roger Smith, from the Royal Veterinary College in Hatsfield, the pioneer of stem cell therapies for equine tendon injuries, will offer his insights into this very revolutionary treatment.
source: press invitation from 10/18/11